Roche said to have rekindled interest in BioMarin Pharmaceutical - sources - part 2

I see Bloomberg was today badgering Dr Severin Schwan, the Roche chief executive, into providing a denial to my BioMarin story from a few weeks ago.

According to the Bloomberg story I read today, Dr Schwan said Roche was looking at small to medium-sized acquistions although he believes biotech valuations are "too high" even after the recent market correction...